THOUSAND OAKS, Calif. (AP) — THOUSAND OAKS, Calif. (AP) — Atara Biotherapeutics Inc. (ATRA) on Thursday reported a loss of $60.5 million in its fourth quarter.
THOUSAND OAKS, Calif. (AP) — THOUSAND OAKS, Calif. (AP) — Atara Biotherapeutics Inc. (ATRA) on Thursday reported a loss of $60.5 million in its fourth quarter.
THOUSAND OAKS, Calif. (AP) — THOUSAND OAKS, Calif. (AP) — Atara Biotherapeutics Inc. (ATRA) on Thursday reported a loss of $60.5 million in its fourth quarter.
The Thousand Oaks, California-based company said it had a loss of 56 cents per share.
The drug developer posted revenue of $4.3 million in the period.
For the year, the company reported that its loss widened to $276.1 million, or $2.61 per share. Revenue was reported as $8.6 million.
The company's shares closed at 70 cents. A year ago, they were trading at $2.97.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ATRA at https://www.zacks.com/ap/ATRA
Join 500,000+ readers who start their day with Quartz.
By subscribing, you agree to our Terms of Service and Privacy Policy.